Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
YPEL5 pseudogene 3 (YPEL5P3) is a non-protein-coding pseudogene located in the human genome and related by sequence to the functional YPEL5 gene. Pseudogenes like YPEL5P3 generally arise from gene duplication or retrotransposition events, resulting in gene copies that accumulate disabling mutations and lose protein-coding potential. Most pseudogenes, including YPEL5P3, do not exhibit independent biological activity, though in rare cases pseudogenes may have regulatory functions or be associated with disease processes—for YPEL5P3, there is no current evidence for such roles. It is classified as a processed pseudogene, not a functional molecular target. YPEL5P3 is not considered a therapeutic target and does not play a direct biological or pharmacological role. It is not targeted by drugs and is not associated with known diseases or biological mechanisms. The regulatory, functional, or pathological relevance of pseudogenes such as YPEL5P3 remains largely unexplored unless specifically identified in research settings. The parent gene, YPEL5 (Yippee like 5), is a conserved protein involved in cell cycle progression and part of a ubiquitin ligase complex.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on YPEL5 pseudogene 3 (YPEL5P3).